These emerging medications , including Wegovy, Mounjaro , and Retatrutide , represent a major advancement in addressing type 2 diabetes and supporting weight loss . They operate by emulating the body’s natural incretin GLP-1 , enabling to regulate blood glucose and decrease cravings. The therapy